icon-folder.gif   Conference Reports for NATAP  
 
  ID Week
October 2-6, 2013
San Francisco
Back grey_arrow_rt.gif
 
 
 
Causes of Death among People with Hepatitis C in NYC, 2000-2011
 
 
  Reported by Jules Levin
IDSA 2013 Oct 2-6 San Francisco, CA
 
Jessie Pinchoff, PhD Candidate, MPH, Ann Drobnik, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Sarah L. Braunstein PhD, Jay K. Varma, MD Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC DOHMH)
 
from Jules: table 1 shows premature death among HCV & coinfected much higher compared to uninfected by either HCV & HIV
 
from Jules: the leading cause of death among mono-infected is liver cancer, see Table 2. among coinfected liver cancer is 2nd leading cause of death after drug-related
 
Jessie Pinchoff, PhD Candidate, MPH, Ann Drobnik, MPH, Jennifer Fuld, PhD Candidate, MA, Katherine Bornschlegel, Sarah L. Braunstein PhD, Jay K. Varma, MD Division of Disease Control, New York City Department of Health and Mental Hygiene (NYC DOHMH)
 
The aging affect of HCV depicted in Figure 2: Rates of deaths due to HCV are increasing as people age
 
"Among persons who died, the majority of people who were HCV mono-infected died prematurely (67%), and nearly all of those who were HCV/HIV co-infected died prematurely (95%) (Figure 1)."
 
"Persons with HCV mono-infection are at increased risk of dying from liver cancer, cirrhosis and drug-related causes compared to New Yorkers without HCV or HIV (Table 2)."
 
Those who are HCV/HIV co-infected are at increased risk of dying of liver cancer and drug-related causes compared to New Yorkers "without HCV or HIV (Table 2)."
 
"Among persons reported with HCV between 2000 and 2010, 18% died between 2000 and 2011."

ID1.gif

ID2.gif

ID3.gif

ID4.gif

ID5.gif